Endometrial hyperplasia risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(8 intermediate revisions by 4 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Endometrial hyperplasia}}
{{Endometrial hyperplasia}}
{{CMG}} {{AE}} {{STM}}
{{CMG}} {{AE}} {{Swathi}}


==Overview==
==Overview==
Common risk factors in the development of endometrial hyperplasia include age>35 years, white race, nulliparity, late [[menopause]], early [[menarche]], [[tamoxifen]] therapy, obesity, [[Lynch syndrome]], history of [[diabetes]], [[gallbladder]] disease, or [[thyroid]] disease, and family history of ovarian, colon, or uterine cancers.<ref name=df>Endometrial Hyperplasia. The American Congress of Obstetricians and Gynecologists. http://www.acog.org/Patients/FAQs/Endometrial-Hyperplasia. Accessedon March 3, 2016.</ref>
Common [[Risk factor|risk factors]] in the [[Development (biology)|development]] of [[endometrial]] [[hyperplasia]] include [[age]]>35 [[Year|years]], white [[race]], [[nulliparity]], late [[menopause]], early [[menarche]], [[tamoxifen]] therapy, [[obesity]], [[Lynch syndrome]], history of [[diabetes]], [[gallbladder]] [[disease]], or [[thyroid]] [[disease]], and [[Family history|family]] [[Family History|history]] of [[ovarian]], [[colon]], or [[uterine]] [[cancers]].


==Risk Factors==
==Risk Factors==
*Common risk factors in the development of endometrial hyperplasia include the following:<ref name=df>Endometrial Hyperplasia. The American Congress of Obstetricians and Gynecologists. http://www.acog.org/Patients/FAQs/Endometrial-Hyperplasia. Accessedon March 3, 2016.</ref>
*Common [[risk factors]] in the [[development]] of [[endometrial]] [[hyperplasia]] include the following:<ref name="df">Endometrial Hyperplasia. The American Congress of Obstetricians and Gynecologists. http://www.acog.org/Patients/FAQs/Endometrial-Hyperplasia. Accessedon March 3, 2016.</ref><ref name="AmantMoerman2005">{{cite journal|last1=Amant|first1=Frederic|last2=Moerman|first2=Philippe|last3=Neven|first3=Patrick|last4=Timmerman|first4=Dirk|last5=Van Limbergen|first5=Erik|last6=Vergote|first6=Ignace|title=Endometrial cancer|journal=The Lancet|volume=366|issue=9484|year=2005|pages=491–505|issn=01406736|doi=10.1016/S0140-6736(05)67063-8}}</ref> <ref name="pmid8736077">{{cite journal |vauthors=Baanders-van Halewyn EA, Blankenstein MA, Thijssen JH, de Ridder CM, de Waard F |title=A comparative study of risk factors for hyperplasia and cancer of the endometrium |journal=Eur. J. Cancer Prev. |volume=5 |issue=2 |pages=105–12 |date=April 1996 |pmid=8736077 |doi= |url=}}</ref><ref name="KreigerMarrett1986">{{cite journal|last1=Kreiger|first1=Nancy|last2=Marrett|first2=Loraine D.|last3=Clarke|first3=E. Aileen|last4=Hilditch|first4=Shelly|last5=Woolever|first5=C. Allan|title=RISK FACTORS FOR ADENOMATOUS ENDOMETRIAL HYPERPLASIA: A CASE-CONTROL STUDY|journal=American Journal of Epidemiology|volume=123|issue=2|year=1986|pages=291–301|issn=1476-6256|doi=10.1093/oxfordjournals.aje.a114237}}</ref><ref name="FarquharLethaby1999">{{cite journal|last1=Farquhar|first1=C.M.|last2=Lethaby|first2=A.|last3=Sowter|first3=M.|last4=Verry|first4=J.|last5=Baranyai|first5=J.|title=An evaluation of risk factors for endometrial hyperplasia in premenopausal women with abnormal menstrual bleeding|journal=American Journal of Obstetrics and Gynecology|volume=181|issue=3|year=1999|pages=525–529|issn=00029378|doi=10.1016/S0002-9378(99)70487-4}}</ref><ref name="Weber1999">{{cite journal|last1=Weber|first1=A|title=Risk factors for endometrial hyperplasia and cancer among women with abnormal bleeding|journal=Obstetrics & Gynecology|volume=93|issue=4|year=1999|pages=594–598|issn=00297844|doi=10.1016/S0029-7844(98)00469-4}}</ref><ref name="EppleinReed2008">{{cite journal|last1=Epplein|first1=M.|last2=Reed|first2=S. D.|last3=Voigt|first3=L. F.|last4=Newton|first4=K. M.|last5=Holt|first5=V. L.|last6=Weiss|first6=N. S.|title=Risk of Complex and Atypical Endometrial Hyperplasia in Relation to Anthropometric Measures and Reproductive History|journal=American Journal of Epidemiology|volume=168|issue=6|year=2008|pages=563–570|issn=0002-9262|doi=10.1093/aje/kwn168}}</ref><ref name="GredmarkKvint1999">{{cite journal|last1=Gredmark|first1=Thomas|last2=Kvint|first2=Sonja|last3=Havel|first3=Guillaume|last4=Mattsson|first4=Lars-Åke|title=Adipose Tissue Distribution in Postmenopausal Women with Adenomatous Hyperplasia of the Endometrium|journal=Gynecologic Oncology|volume=72|issue=2|year=1999|pages=138–142|issn=00908258|doi=10.1006/gyno.1998.5252}}</ref>  
**Age (>than 35 years)
**[[Age]] (>than 35 years)
**White race
**White [[race]]
**Nulliparity
**Nulliparity
**Late [[menopause]] (age > 55)
**Late [[menopause]] (age > 55)
**Early [[menarche]]
**Early [[menarche]]
**History of [[diabetes mellitus]], [[gallbladder]] disease, or [[thyroid]] disease
**History of [[diabetes mellitus]], [[gallbladder]] [[disease]], or [[thyroid]] [[disease]]
**Obesity
**[[Obesity]]
**[[Tamoxifen]] therapy
**[[Tamoxifen]] therapy
**Family history of ovarian, colon, or uterine cancer
**[[Family history]] of [[ovarian]], [[colon]], or [[uterine]] [[cancer]]
**[[Lynch syndrome]]
**[[Lynch syndrome]]
 
**[[Smoking]]
**[[Menopause|Menopausual]] [[hormonal]] therapy
==References==
==References==
{{reflist|2}}
{{reflist|2}}
Line 27: Line 28:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Gynecology]]
[[Category:Surgery]]

Latest revision as of 11:24, 8 May 2019

Endometrial hyperplasia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Endometrial hyperplasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Case Studies

Case #1

Endometrial hyperplasia risk factors On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Endometrial hyperplasia risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Endometrial hyperplasia risk factors

CDC on Endometrial hyperplasia risk factors

Endometrial hyperplasia risk factors in the news

Blogs on Endometrial hyperplasia risk factors

Directions to Hospitals Treating Endometrial hyperplasia

Risk calculators and risk factors for Endometrial hyperplasia risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Swathi Venkatesan, M.B.B.S.[2]

Overview

Common risk factors in the development of endometrial hyperplasia include age>35 years, white race, nulliparity, late menopause, early menarche, tamoxifen therapy, obesity, Lynch syndrome, history of diabetes, gallbladder disease, or thyroid disease, and family history of ovarian, colon, or uterine cancers.

Risk Factors

References

  1. Endometrial Hyperplasia. The American Congress of Obstetricians and Gynecologists. http://www.acog.org/Patients/FAQs/Endometrial-Hyperplasia. Accessedon March 3, 2016.
  2. Amant, Frederic; Moerman, Philippe; Neven, Patrick; Timmerman, Dirk; Van Limbergen, Erik; Vergote, Ignace (2005). "Endometrial cancer". The Lancet. 366 (9484): 491–505. doi:10.1016/S0140-6736(05)67063-8. ISSN 0140-6736.
  3. Baanders-van Halewyn EA, Blankenstein MA, Thijssen JH, de Ridder CM, de Waard F (April 1996). "A comparative study of risk factors for hyperplasia and cancer of the endometrium". Eur. J. Cancer Prev. 5 (2): 105–12. PMID 8736077.
  4. Kreiger, Nancy; Marrett, Loraine D.; Clarke, E. Aileen; Hilditch, Shelly; Woolever, C. Allan (1986). "RISK FACTORS FOR ADENOMATOUS ENDOMETRIAL HYPERPLASIA: A CASE-CONTROL STUDY". American Journal of Epidemiology. 123 (2): 291–301. doi:10.1093/oxfordjournals.aje.a114237. ISSN 1476-6256.
  5. Farquhar, C.M.; Lethaby, A.; Sowter, M.; Verry, J.; Baranyai, J. (1999). "An evaluation of risk factors for endometrial hyperplasia in premenopausal women with abnormal menstrual bleeding". American Journal of Obstetrics and Gynecology. 181 (3): 525–529. doi:10.1016/S0002-9378(99)70487-4. ISSN 0002-9378.
  6. Weber, A (1999). "Risk factors for endometrial hyperplasia and cancer among women with abnormal bleeding". Obstetrics & Gynecology. 93 (4): 594–598. doi:10.1016/S0029-7844(98)00469-4. ISSN 0029-7844.
  7. Epplein, M.; Reed, S. D.; Voigt, L. F.; Newton, K. M.; Holt, V. L.; Weiss, N. S. (2008). "Risk of Complex and Atypical Endometrial Hyperplasia in Relation to Anthropometric Measures and Reproductive History". American Journal of Epidemiology. 168 (6): 563–570. doi:10.1093/aje/kwn168. ISSN 0002-9262.
  8. Gredmark, Thomas; Kvint, Sonja; Havel, Guillaume; Mattsson, Lars-Åke (1999). "Adipose Tissue Distribution in Postmenopausal Women with Adenomatous Hyperplasia of the Endometrium". Gynecologic Oncology. 72 (2): 138–142. doi:10.1006/gyno.1998.5252. ISSN 0090-8258.

Template:WikiDoc Sources